2,020
Views
0
CrossRef citations to date
0
Altmetric
Report

Structure- and machine learning-guided engineering demonstrate that a non-canonical disulfide in an anti-PD-1 rabbit antibody does not impede antibody developability

, , , , , , , , , , , & show all
Article: 2309685 | Received 12 Nov 2023, Accepted 21 Jan 2024, Published online: 14 Feb 2024

References

  • Mage RG, Esteves PJ, Rader C. Rabbit models of human diseases for diagnostics and therapeutics development. Dev Comp Immunol. 2019;92:99–13. doi:10.1016/j.dci.2018.10.003. PMID: 30339876.
  • Weber J, Peng H, Rader C. From rabbit antibody repertoires to rabbit monoclonal antibodies. Experimental & Molecular Medicine. 2017;49(3):e305. doi:10.1038/emm.2017.23. PMID: 28336958.
  • Arai H, Glabe C, Luecke H. Crystal structure of a conformation-dependent rabbit IgG fab specific for amyloid prefibrillar oligomers. Biochim Biophys Acta. 2012;1820(12):1908–14. doi:10.1016/j.bbagen.2012.08.016. PMID: 22940003.
  • Pan R, Sampson JM, Chen Y, Vaine M, Wang S, Lu S, Kong XP. Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1-infected humans. J Virol. 2013;87(18):10221–31. doi:10.1128/JVI.00843-13. PMID: 23864637.
  • Prabakaran P, Chowdhury PS. Landscape of non-canonical cysteines in human V. Cell Rep. 2020;31(13):107831. doi:10.1016/j.celrep.2020.107831. PMID: 32610132.
  • Dondelinger M, Filée P, Sauvage E, Quinting B, Muyldermans S, Galleni M, Vandevenne MS. Understanding the significance and implications of antibody numbering and antigen-binding surface/residue definition. Front Immunol. 2018;9:2278. doi:10.3389/fimmu.2018.02278. PMID: 30386328.
  • Kawade R, Akiba H, Entzminger K, Maruyama T, Okumura CJ, Tsumoto K, Barrick D. Roles of the disulfide bond between the variable and the constant domains of rabbit immunoglobulin kappa chains in thermal stability and affinity. Protein Eng Des Sel. 2018;31(7–8):243–47. doi:10.1093/protein/gzy008. PMID: 29850878.
  • McDermott DF, Atkins MB. PD-1 as a potential target in cancer therapy. Cancer Med. 2013;2(5):662–73. doi:10.1002/cam4.106. PMID: 24403232.
  • Dauparas J, Anishchenko I, Bennett N, Bai H, Ragotte RJ, Milles LF, Wicky BIM, Courbet A, de Haas RJ, Bethel N. et al. Robust deep learning–based protein sequence design using ProteinMPNN. Sci. 2022;378(6615):49–56. doi:10.1126/science.add2187. PMID: 36108050.
  • Lin W, Liang WC, Nguy T, Maia M, Tyagi T, Chiu C, Hoi KH, Chen Y, Wu Y, Karagiannis SN. Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology. PloS ONE. 2020;15(12):e0244158. doi:10.1371/journal.pone.0244158. PMID: 33347473.
  • Shire SJ, Shahrokh Z, Liu J. Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004;93:1390–402. doi:10.1002/jps.20079. PMID:5124199.
  • Kellogg EH, Leaver-Fay A, Baker D. Role of conformational sampling in computing mutation-induced changes in protein structure and stability. Proteins. 2011;79(3):830–38. doi:10.1002/prot.22921. PMID: 21287615.
  • Chaudhury S, Lyskov S, Gray JJ. PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta. Bioinformatics. 2010;26(5):689–91. doi:10.1093/bioinformatics/btq007. PMID: 20061306.
  • Park H, Bradley P, Greisen P, Liu Y, Mulligan VK, Kim DE, Baker D, DiMaio F. Simultaneous Optimization of Biomolecular Energy Functions on Features from Small Molecules and Macromolecules. J Chem Theory Comput. 2016;12(12):6201–12. doi:10.1021/acs.jctc.6b00819. PMID: 27766851.
  • Sora V, Laspiur AO, Degn K, Arnaudi M, Utichi M, Beltrame L, De Menezes D, Orlandi M, Stoltze UK, Rigina O. et al. RosettaDDGPrediction for high-throughput mutational scans: from stability to binding. Protein Sci. 2023;32(1):e4527. doi:10.1002/pro.4527. PMID: 36461907.
  • Mendoza MN, Jian M, King MT, Brooks CL. Role of a noncanonical disulfide bond in the stability, affinity, and flexibility of a VHH specific for the listeria virulence factor InlB. Protein Sci. 2020;29(4):1004–17. doi:10.1002/pro.3831. PMID: 31981247.
  • Popkov M, Mage RG, Alexander CB, Thundivalappil S, Barbas CF, Rader C. Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. J Mol Biol. 2003;325:325–35. doi:10.1016/s0022-2836(02)01232-9. PMID:2488098.
  • Lefranc MP, Giudicelli V, Ginestoux C, Bodmer J, Müller W, Bontrop R, Lemaitre M, Malik A, Barbié V, Chaume D. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 1999;27:209–12. doi:10.1093/nar/27.1.209. PMID: 9847182.
  • Foote J, Winter G. Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol. 1992;224:487–99. doi:10.1016/0022-2836(92)91010-m. PMID:560463.
  • Zak KM, Kitel R, Przetocka S, Golik P, Guzik K, Musielak B, Dömling A, Dubin G, Holak TA. Structure of the complex of human programmed death, PD-1, and its ligand PD-L1. Structure. 2015;23:2341–48. doi:10.1016/j.str.2015.09.010. PMID: 26602187.
  • Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, Paciorek W, Womack T, Bricogne G. Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D Biol Crystallogr. 2011;67(4):293–302. doi:10.1107/S0907444911007773. PMID: 21460447.
  • McCoy AJ, Grosse-Kunstleve RW, Storoni LC, Read RJ. Likelihood-enhanced fast translation functions. Acta Crystallogr D Biol Crystallogr. 2005;61(4):458–64. doi:10.1107/S0907444905001617. PMID:5805601.
  • Tang S, Kim PS. A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery. Proc Natl Acad Sci U S A. 2019;116:24500–06. doi:10.1073/pnas.1916916116. PMID: 31727844.
  • Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW, Leahy DJ. Structure of the extracellular region of HER2 alone and in complex with the herceptin fab. Nature. 2003;421:756–60. doi:10.1038/nature01392. PMID:2610629.
  • Phad GE, Pushparaj P, Tran K, Dubrovskaya V, Àdori M, Martinez-Murillo P, Vázquez Bernat N, Singh S, Dionne G, O’Dell S. et al. Extensive dissemination and intraclonal maturation of HIV env vaccine-induced B cell responses. J Exp Med. 2020;217. doi:10.1084/jem.20191155. PMID: 31704807.
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004;60(12):2126–32. doi:10.1107/S0907444904019158. PMID:5572765.
  • Liebschner D, Afonine PV, Baker ML, Bunkóczi G, Chen VB, Croll TI, Hintze B, Hung LW, Jain S, McCoy AJ. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019;75(10):861–77. doi:10.1107/S2059798319011471. PMID: 31588918.
  • Ito S, Ikuno T, Mishima M, Yano M, Hara T, Kuramochi T, Sampei Z, Wakabayashi T, Tabo M, Chiba S. et al. In vitro human helper T-cell assay to screen antibody drug candidates for immunogenicity. J Immunotoxicol. 2019;16(1):125–32. doi:10.1080/1547691X.2019.1604586. PMID: 31179789.
  • Ridker PM, Tardif JC, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S. et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. N Engl J Med. 2017;376(16):1517–26. doi:10.1056/NEJMoa1614062. PMID: 28304227.
  • Xu A, Kim HS, Estee S, ViaJar S, Galush WJ, Gill A, Hötzel I, Lazar GA, McDonald P, Andersen N. et al. Susceptibility of antibody CDR residues to chemical modifications can be revealed prior to antibody humanization and aid in the lead selection process. Mol Pharm. 2018;15(10):4529–37. doi:10.1021/acs.molpharmaceut.8b00536. PMID: 30118239.
  • Alford RF, Leaver-Fay A, Jeliazkov JR, O’Meara MJ, DiMaio FP, Park H, Shapovalov MV, Renfrew PD, Mulligan VK, Kappel K. et al. The Rosetta all-atom energy function for macromolecular modeling and design. J Chem Theory Comput. 2017;13(6):3031–48. doi:10.1021/acs.jctc.7b00125. PMID: 28430426.